About
Technology
Issues
FAQ
Search
Profile
Schools
Top Authors
Prolific Authors
Top Journals
Main Disciplines
Scientometrics
Avg. Impact Factor
Discipline Ranks
h
-index
g
-index
★★
Articles
★★★
Articles
Article Citations
Citation Distribution
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Institutions
›
Eastern Cooperative Oncology Group
›
top-articles
Eastern Cooperative Oncology Group
15
(top 1%)
papers
526
(top 1%)
citations
8
(top 1%)
h
-index
14
(top 1%)
g
-index
16
all documents
541
doc citations
286
citing journals
Top Articles
#
Title
Journal
Year
Citations
1
Malignant “Triton” tumors. Natural history and immunohistochemistry of nine new cases with literature review
Cancer
1985
202
2
Does extent of surgery influence outcome for astrocytoma with atypical or anaplastic foci (AAF)? A report from three Radiation Therapy Oncology Group (RTOG) trials
Journal of Neuro-Oncology
1992
109
3
Neuropathy Is Not Associated With Clinical Outcomes in Patients Receiving Adjuvant Taxane-Containing Therapy for Operable Breast Cancer
Journal of Clinical Oncology
2012
83
4
Genetic predictors of taxane-induced neurotoxicity in a SWOG phase III intergroup adjuvant breast cancer treatment trial (S0221)
Breast Cancer Research and Treatment
2011
59
5
Relationship between elevated immunoglobulin free light chain and the presence of IgH translocations in multiple myeloma
Leukemia
2010
34
6
Very Poor Survival of Patients with AML Who Relapse after Achieving a First Complete Remission: The Eastern Cooperative Oncology Group Experience.
Blood
2005
22
7
Outcome with Lenalidomide Plus Dexamethasone Followed by Early Autologous Stem Cell Transplantation In the ECOG E4A03 Randomized Clinical Trial
Blood
2010
16
8
In Adults with Standard-Risk Acute Lymphoblastic Leukemia (ALL) the Greatest Benefit Is Achieved from an Allogeneic Transplant in First Complete Remission (CR) and an Autologous Transplant Is Less Effective Than Conventional Consolidation/Maintenance Chemotherapy: Final Results of the International ALL Trial (MRC UKALL XII/ECOG E2993).
Blood
2006
8
9
Minimal Residual Disease (MRD) and Risk of Relapse in Acute Promyelocytic Leukemia (APL): Insights from the North American Intergroup Phase III Trial C9710.
Blood
2006
2
10
Final Analysis of a Randomized Comparison of ABVD Chemotherapy with a Strategy That Includes Radiation Therapy (RT) in Patients with Limited-Stage Hodgkin Lymphoma (HL): NCIC CTG/ECOG HD.6
Blood
2011
2
11
Does Concomitant Methotrexate (MTX) and GM-CSF Administration after Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) Predispose to Thrombotic Microangiopathy (TMA)?.
Blood
2004
1
12
Frequent PML-RAR α Mutations in Relapse Patients on Acute Promyelocytic Leukemia (APL) Intergroup Phase III Trial C9710.
Blood
2006
1
13
Who Participates in an Adult Cooperative Group Trial for Adolescent and Young Adults (AYAs)? Baseline Demographic and Psychosocial Characteristics of AYAs Enrolled On Intergroup Trial C10403 for Acute Lymphoblastic Leukemia (ALL)
Blood
2012
1
14
Gene Risk Scores Based on Expression of 6 Genes Quanitated by Nuclease Protection Assay in Formalin Fixed Paraffin-Embedded Tissue (FFPET) Specimens From CHOP and RCHOP Treated Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Predict Outcome: An ECOG and SWOG Study
Blood
2011
1
15
Editorial to the IJPO supplement on childhood obesity
Pediatric Obesity
2008
0
16
Early Results of Pentostatin, Cytoxan, Rituximab (PCR) Followed by CAMPATH-H (CA) for the Treatment of Relapse/Refractory Chronic Lymphocytic Leukemia (CLL) in ECOG Protocol E2903.
Blood
2007
0
site/software ©
exaly
; All materials licenced under
CC by-SA
.